Report Overview:
Hepatitis B vaccine is a vaccine that prevents hepatitis B.
The Global Hepatitis B Vaccine (Recombinant) Market Size was estimated at USD 852.56 million in 2023 and is projected to reach USD 1023.95 million by 2029, exhibiting a CAGR of 3.10% during the forecast period.
This report provides a deep insight into the global Hepatitis B Vaccine (Recombinant) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter?s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hepatitis B Vaccine (Recombinant) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hepatitis B Vaccine (Recombinant) market in any manner.
Global Hepatitis B Vaccine (Recombinant) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GSK
Merck
Sanofi Pasteur
Dynavax Technologies
LG Life Sciences
KM Biologics
Shenzhen Kangtai Biological Products
Serum Institute
Market Segmentation (by Type)
10mcg/0.5ml
10mcg/ml
Market Segmentation (by Application)
Newborn
Adult
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Hepatitis B Vaccine (Recombinant) Market
? Overview of the regional outlook of the Hepatitis B Vaccine (Recombinant) Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hepatitis B Vaccine (Recombinant) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hepatitis B Vaccine (Recombinant)
1.2 Key Market Segments
1.2.1 Hepatitis B Vaccine (Recombinant) Segment by Type
1.2.2 Hepatitis B Vaccine (Recombinant) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Hepatitis B Vaccine (Recombinant) Market Overview
2.1 Global Market Overview
2.1.1 Global Hepatitis B Vaccine (Recombinant) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hepatitis B Vaccine (Recombinant) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Hepatitis B Vaccine (Recombinant) Market Competitive Landscape
3.1 Global Hepatitis B Vaccine (Recombinant) Sales by Manufacturers (2019-2024)
3.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Manufacturers (2019-2024)
3.3 Hepatitis B Vaccine (Recombinant) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hepatitis B Vaccine (Recombinant) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hepatitis B Vaccine (Recombinant) Sales Sites, Area Served, Product Type
3.6 Hepatitis B Vaccine (Recombinant) Market Competitive Situation and Trends
3.6.1 Hepatitis B Vaccine (Recombinant) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hepatitis B Vaccine (Recombinant) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Hepatitis B Vaccine (Recombinant) Industry Chain Analysis
4.1 Hepatitis B Vaccine (Recombinant) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hepatitis B Vaccine (Recombinant) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Hepatitis B Vaccine (Recombinant) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2019-2024)
6.3 Global Hepatitis B Vaccine (Recombinant) Market Size Market Share by Type (2019-2024)
6.4 Global Hepatitis B Vaccine (Recombinant) Price by Type (2019-2024)
7 Hepatitis B Vaccine (Recombinant) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hepatitis B Vaccine (Recombinant) Market Sales by Application (2019-2024)
7.3 Global Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Application (2019-2024)
7.4 Global Hepatitis B Vaccine (Recombinant) Sales Growth Rate by Application (2019-2024)
8 Hepatitis B Vaccine (Recombinant) Market Segmentation by Region
8.1 Global Hepatitis B Vaccine (Recombinant) Sales by Region
8.1.1 Global Hepatitis B Vaccine (Recombinant) Sales by Region
8.1.2 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region
8.2 North America
8.2.1 North America Hepatitis B Vaccine (Recombinant) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hepatitis B Vaccine (Recombinant) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 GSK
9.1.1 GSK Hepatitis B Vaccine (Recombinant) Basic Information
9.1.2 GSK Hepatitis B Vaccine (Recombinant) Product Overview
9.1.3 GSK Hepatitis B Vaccine (Recombinant) Product Market Performance
9.1.4 GSK Business Overview
9.1.5 GSK Hepatitis B Vaccine (Recombinant) SWOT Analysis
9.1.6 GSK Recent Developments
9.2 Merck
9.2.1 Merck Hepatitis B Vaccine (Recombinant) Basic Information
9.2.2 Merck Hepatitis B Vaccine (Recombinant) Product Overview
9.2.3 Merck Hepatitis B Vaccine (Recombinant) Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Hepatitis B Vaccine (Recombinant) SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Sanofi Pasteur
9.3.1 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Basic Information
9.3.2 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Overview
9.3.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Market Performance
9.3.4 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) SWOT Analysis
9.3.5 Sanofi Pasteur Business Overview
9.3.6 Sanofi Pasteur Recent Developments
9.4 Dynavax Technologies
9.4.1 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Basic Information
9.4.2 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Overview
9.4.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Market Performance
9.4.4 Dynavax Technologies Business Overview
9.4.5 Dynavax Technologies Recent Developments
9.5 LG Life Sciences
9.5.1 LG Life Sciences Hepatitis B Vaccine (Recombinant) Basic Information
9.5.2 LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Overview
9.5.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Market Performance
9.5.4 LG Life Sciences Business Overview
9.5.5 LG Life Sciences Recent Developments
9.6 KM Biologics
9.6.1 KM Biologics Hepatitis B Vaccine (Recombinant) Basic Information
9.6.2 KM Biologics Hepatitis B Vaccine (Recombinant) Product Overview
9.6.3 KM Biologics Hepatitis B Vaccine (Recombinant) Product Market Performance
9.6.4 KM Biologics Business Overview
9.6.5 KM Biologics Recent Developments
9.7 Shenzhen Kangtai Biological Products
9.7.1 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Basic Information
9.7.2 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Overview
9.7.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Market Performance
9.7.4 Shenzhen Kangtai Biological Products Business Overview
9.7.5 Shenzhen Kangtai Biological Products Recent Developments
9.8 Serum Institute
9.8.1 Serum Institute Hepatitis B Vaccine (Recombinant) Basic Information
9.8.2 Serum Institute Hepatitis B Vaccine (Recombinant) Product Overview
9.8.3 Serum Institute Hepatitis B Vaccine (Recombinant) Product Market Performance
9.8.4 Serum Institute Business Overview
9.8.5 Serum Institute Recent Developments
10 Hepatitis B Vaccine (Recombinant) Market Forecast by Region
10.1 Global Hepatitis B Vaccine (Recombinant) Market Size Forecast
10.2 Global Hepatitis B Vaccine (Recombinant) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hepatitis B Vaccine (Recombinant) Market Size Forecast by Country
10.2.3 Asia Pacific Hepatitis B Vaccine (Recombinant) Market Size Forecast by Region
10.2.4 South America Hepatitis B Vaccine (Recombinant) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hepatitis B Vaccine (Recombinant) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Hepatitis B Vaccine (Recombinant) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hepatitis B Vaccine (Recombinant) by Type (2025-2030)
11.1.2 Global Hepatitis B Vaccine (Recombinant) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hepatitis B Vaccine (Recombinant) by Type (2025-2030)
11.2 Global Hepatitis B Vaccine (Recombinant) Market Forecast by Application (2025-2030)
11.2.1 Global Hepatitis B Vaccine (Recombinant) Sales (Kilotons) Forecast by Application
11.2.2 Global Hepatitis B Vaccine (Recombinant) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hepatitis B Vaccine (Recombinant) Market Size Comparison by Region (M USD)
Table 5. Global Hepatitis B Vaccine (Recombinant) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hepatitis B Vaccine (Recombinant) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccine (Recombinant) as of 2022)
Table 10. Global Market Hepatitis B Vaccine (Recombinant) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hepatitis B Vaccine (Recombinant) Sales Sites and Area Served
Table 12. Manufacturers Hepatitis B Vaccine (Recombinant) Product Type
Table 13. Global Hepatitis B Vaccine (Recombinant) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hepatitis B Vaccine (Recombinant)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hepatitis B Vaccine (Recombinant) Market Challenges
Table 22. Global Hepatitis B Vaccine (Recombinant) Sales by Type (Kilotons)
Table 23. Global Hepatitis B Vaccine (Recombinant) Market Size by Type (M USD)
Table 24. Global Hepatitis B Vaccine (Recombinant) Sales (Kilotons) by Type (2019-2024)
Table 25. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2019-2024)
Table 26. Global Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Type (2019-2024)
Table 27. Global Hepatitis B Vaccine (Recombinant) Market Size Share by Type (2019-2024)
Table 28. Global Hepatitis B Vaccine (Recombinant) Price (USD/Ton) by Type (2019-2024)
Table 29. Global Hepatitis B Vaccine (Recombinant) Sales (Kilotons) by Application
Table 30. Global Hepatitis B Vaccine (Recombinant) Market Size by Application
Table 31. Global Hepatitis B Vaccine (Recombinant) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2019-2024)
Table 33. Global Hepatitis B Vaccine (Recombinant) Sales by Application (2019-2024) & (M USD)
Table 34. Global Hepatitis B Vaccine (Recombinant) Market Share by Application (2019-2024)
Table 35. Global Hepatitis B Vaccine (Recombinant) Sales Growth Rate by Application (2019-2024)
Table 36. Global Hepatitis B Vaccine (Recombinant) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2019-2024)
Table 38. North America Hepatitis B Vaccine (Recombinant) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Hepatitis B Vaccine (Recombinant) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Region (2019-2024) & (Kilotons)
Table 43. GSK Hepatitis B Vaccine (Recombinant) Basic Information
Table 44. GSK Hepatitis B Vaccine (Recombinant) Product Overview
Table 45. GSK Hepatitis B Vaccine (Recombinant) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GSK Business Overview
Table 47. GSK Hepatitis B Vaccine (Recombinant) SWOT Analysis
Table 48. GSK Recent Developments
Table 49. Merck Hepatitis B Vaccine (Recombinant) Basic Information
Table 50. Merck Hepatitis B Vaccine (Recombinant) Product Overview
Table 51. Merck Hepatitis B Vaccine (Recombinant) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Hepatitis B Vaccine (Recombinant) SWOT Analysis
Table 54. Merck Recent Developments
Table 55. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Basic Information
Table 56. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Overview
Table 57. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) SWOT Analysis
Table 59. Sanofi Pasteur Business Overview
Table 60. Sanofi Pasteur Recent Developments
Table 61. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Basic Information
Table 62. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Overview
Table 63. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Dynavax Technologies Business Overview
Table 65. Dynavax Technologies Recent Developments
Table 66. LG Life Sciences Hepatitis B Vaccine (Recombinant) Basic Information
Table 67. LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Overview
Table 68. LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. LG Life Sciences Business Overview
Table 70. LG Life Sciences Recent Developments
Table 71. KM Biologics Hepatitis B Vaccine (Recombinant) Basic Information
Table 72. KM Biologics Hepatitis B Vaccine (Recombinant) Product Overview
Table 73. KM Biologics Hepatitis B Vaccine (Recombinant) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. KM Biologics Business Overview
Table 75. KM Biologics Recent Developments
Table 76. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Basic Information
Table 77. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Overview
Table 78. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Shenzhen Kangtai Biological Products Business Overview
Table 80. Shenzhen Kangtai Biological Products Recent Developments
Table 81. Serum Institute Hepatitis B Vaccine (Recombinant) Basic Information
Table 82. Serum Institute Hepatitis B Vaccine (Recombinant) Product Overview
Table 83. Serum Institute Hepatitis B Vaccine (Recombinant) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Serum Institute Business Overview
Table 85. Serum Institute Recent Developments
Table 86. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 87. Global Hepatitis B Vaccine (Recombinant) Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Hepatitis B Vaccine (Recombinant) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 89. North America Hepatitis B Vaccine (Recombinant) Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Hepatitis B Vaccine (Recombinant) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 91. Europe Hepatitis B Vaccine (Recombinant) Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 93. Asia Pacific Hepatitis B Vaccine (Recombinant) Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Hepatitis B Vaccine (Recombinant) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 95. South America Hepatitis B Vaccine (Recombinant) Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Hepatitis B Vaccine (Recombinant) Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 99. Global Hepatitis B Vaccine (Recombinant) Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Hepatitis B Vaccine (Recombinant) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 101. Global Hepatitis B Vaccine (Recombinant) Sales (Kilotons) Forecast by Application (2025-2030)
Table 102. Global Hepatitis B Vaccine (Recombinant) Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Hepatitis B Vaccine (Recombinant)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hepatitis B Vaccine (Recombinant) Market Size (M USD), 2019-2030
Figure 5. Global Hepatitis B Vaccine (Recombinant) Market Size (M USD) (2019-2030)
Figure 6. Global Hepatitis B Vaccine (Recombinant) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hepatitis B Vaccine (Recombinant) Market Size by Country (M USD)
Figure 11. Hepatitis B Vaccine (Recombinant) Sales Share by Manufacturers in 2023
Figure 12. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Manufacturers in 2023
Figure 13. Hepatitis B Vaccine (Recombinant) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hepatitis B Vaccine (Recombinant) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hepatitis B Vaccine (Recombinant) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hepatitis B Vaccine (Recombinant) Market Share by Type
Figure 18. Sales Market Share of Hepatitis B Vaccine (Recombinant) by Type (2019-2024)
Figure 19. Sales Market Share of Hepatitis B Vaccine (Recombinant) by Type in 2023
Figure 20. Market Size Share of Hepatitis B Vaccine (Recombinant) by Type (2019-2024)
Figure 21. Market Size Market Share of Hepatitis B Vaccine (Recombinant) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hepatitis B Vaccine (Recombinant) Market Share by Application
Figure 24. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2019-2024)
Figure 25. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application in 2023
Figure 26. Global Hepatitis B Vaccine (Recombinant) Market Share by Application (2019-2024)
Figure 27. Global Hepatitis B Vaccine (Recombinant) Market Share by Application in 2023
Figure 28. Global Hepatitis B Vaccine (Recombinant) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2019-2024)
Figure 30. North America Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2023
Figure 32. U.S. Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Hepatitis B Vaccine (Recombinant) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Hepatitis B Vaccine (Recombinant) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2023
Figure 37. Germany Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales Market Share by Region in 2023
Figure 44. China Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (Kilotons)
Figure 50. South America Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2023
Figure 51. Brazil Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Hepatitis B Vaccine (Recombinant) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hepatitis B Vaccine (Recombinant) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hepatitis B Vaccine (Recombinant) Market Share Forecast by Type (2025-2030)
Figure 65. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Application (2025-2030)
Figure 66. Global Hepatitis B Vaccine (Recombinant) Market Share Forecast by Application (2025-2030)
